AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 1 filers reported holding AKCEA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,000 | – | 64 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 2,389,571 | $61,197,000 | 1.69% |
Virtus ETF Advisers LLC | 39,351 | $1,008,000 | 0.88% |
Eventide Asset Management | 175,000 | $4,482,000 | 0.21% |
ALTRINSIC GLOBAL ADVISORS LLC | 187,800 | $4,810,000 | 0.19% |
Bellevue Group AG | 48,799 | $1,250,000 | 0.12% |
Perceptive Advisors | 97,144 | $2,488,000 | 0.07% |
FMR LLC | 10,008,016 | $256,306,000 | 0.03% |
WELLINGTON MANAGEMENT GROUP LLP | 3,384,101 | $86,667,000 | 0.02% |
Virtu Financial LLC | 12,571 | $322,000 | 0.02% |
Cubist Systematic Strategies, LLC | 7,843 | $201,000 | 0.01% |